MPJE Drug Substitution and Generic Drug Laws 3

Question 1

Which of the following statements about an 'AA' rating in the Orange Book is TRUE?

Accepted Answer

The drug is a conventional dosage form with no bioequivalence concerns and no known equivalent

Answer

An 'AA' rating is assigned to conventional dosage forms that have no bioequivalence issues—these are typically products where there is no other marketed version to compare against.

Question 2

Under state drug product selection laws, pharmacists are generally:

Accepted Answer

Permitted but not required to substitute a therapeutically equivalent generic

Answer

State drug product selection laws authorize pharmacists to substitute therapeutically equivalent generics but do not mandate it, and they preserve both prescriber and patient override rights.

Question 3

A prescription written with a brand name followed by the notation 'or equivalent' indicates:

Accepted Answer

The pharmacist may dispense a therapeutically equivalent generic product

Answer

When a prescriber writes 'or equivalent,' it constitutes explicit consent for the pharmacist to substitute a therapeutically equivalent product as listed in the Orange Book.

Question 4

Which amendment to the Food, Drug, and Cosmetic Act first required manufacturers to prove both safety AND efficacy before marketing a new drug?

Accepted Answer

Kefauver-Harris Amendment of 1962

Answer

The Kefauver-Harris Amendment of 1962 established the dual requirement that new drugs be proven both safe and effective, triggered by the thalidomide tragedy in Europe.

Question 5

A 'BX' rating in the Orange Book indicates:

Accepted Answer

Data are insufficient to determine therapeutic equivalence at this time

Answer

A 'BX' rating means FDA currently lacks sufficient data to classify the drug as therapeutically equivalent, placing it in a 'B' category by default.

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE - Multistate Pharmacy Jurisprudence Examination Practice Test

MPJE Drug Substitution and Generic Drug Laws 3